CD274 and neoplasm: The nanoplatform, utilizing an arginine fragment and hyaluronic acid skeleton, actively targeted tumor sites and released Epirubicin and the autophagy inducer STF‐62247, in combination with a PD‐L1 inhibitor. By inducing autophagic cell death, it enhanced the efficacy of both chemotherapy and immunotherapy in tumor treatment.